Resultats globals: 14 registres trobats en 0.01 segons.
Articles, 11 registres trobats
Documents de recerca, 3 registres trobats
Articles 11 registres trobats  1 - 10següent  anar al registre:
1.
9 p, 1.5 MB Advances and unmet needs in genetic, basic and clinical science in Alport syndrome : report from the 2015 International Workshop on Alport Syndrome / Gross, Oliver (University Medicine Goettingen (Germany)) ; Kashtan, Clifford E. (University of Minnesota Medical School (USA)) ; Rheault, Michelle N. (University of Minnesota Medical School (USA)) ; Flinter, Frances (Guy's and St Thomas' NHS Foundation Trust (United Kingdom)) ; Savige, Judith (The University of Melbourne (Australia)) ; Miner, Jeffrey H. (Washington University School of Medicine (USA)) ; Torra, Roser (Institut d'Investigació Biomèdica Sant Pau) ; Ars, Elisabet (Institut d'Investigació Biomèdica Sant Pau) ; Deltas, Constantinos (University of Cyprus) ; Savva, Isavella (University of Cyprus) ; Perin, Laura (University of Southern California, Children's Hospital Los Angeles (USA)) ; Renieri, Alessandra (University of Siena (Italy)) ; Ariani, Francesca (University of Siena (Italy)) ; Mari, Francesca (University of Siena (Italy)) ; Baigent, Colin (University of Oxford (United Kingdom)) ; Judge, Parminder (University of Oxford (United Kingdom)) ; Knebelman, Bertrand (Université Paris Descartes (France)) ; Heidet, Laurence (Clinique Maurice Lamy, Hôpital Necker-Enfants Malades (France)) ; Lagas, Sharon (Alport Syndrome Foundation (USA)) ; Blatt, Dave (Alport Foundation of Australia) ; Ding, Jie (Peking University First Hospital (China)) ; Zhang, Yanqin (Peking University First Hospital (China)) ; Gale, Daniel P. (University College London-Centre for Nephrology (United Kingdom)) ; Prunotto, Marco (F. Hoffmann-La Roche Ltd. Roche Pharma Research & Early Development (Switzerland)) ; Xue, Yong (Global Clinical Development. Sanofi Genzyme (The Netherlands)) ; Schachter, Asher D. (Novartis Institutes for BioMedical Research (USA)) ; Morton, Lori C.G. (Regeneron Pharmaceuticals (USA)) ; Blem, Jacqui (Regulus Therapeutics (USA)) ; Huang, Michael (Regulus Therapeutics (USA)) ; Liu, Shiguang (Sanofi-Genzyme R&D Center (USA)) ; Vallee, Sebastien (Discovery Biology. Shire (USA)) ; Renault, Daniel (FEDERG (Belgium)) ; Schifter, Julia (Alport Israel) ; Skelding, Jules (Alport UK (United Kingdom)) ; Gear, Susie (Alport UK (United Kingdom)) ; Friede, Tim (University Medical Center Goettingen (Germany)) ; Turner, A. Neil (University of Edinburgh (United Kingdom)) ; Lennon, Rachel (University of Manchester (United Kingdom)) ; Universitat Autònoma de Barcelona
Alport syndrome (AS) is a genetic disease characterized by haematuric glomerulopathy variably associated with hearing loss and anterior lenticonus. It is caused by mutations in the COL4A3, COL4A4 or COL4A5 genes encoding the α3α4α5(IV) collagen heterotrimer. [...]
2017 - 10.1093/ndt/gfw095
Nephrology Dialysis Transplantation, Vol. 32, Issue 6 (June 2017) , p. 916-924  
2.
10 p, 832.8 KB Recommendations for imaging-based diagnosis and management of renal angiomyolipoma associated with tuberous sclerosis complex / Buj Pradilla, María José (Hospital Universitario 12 de Octubre) ; Martí Ballesté, Teresa (Institut d'Investigació Biomèdica Sant Pau) ; Torra, Roser (Institut d'Investigació Biomèdica Sant Pau) ; Villacampa Aubá, Felipe (Hospital Universitario 12 de Octubre)
Renal angiomyolipomas are found in up to 80% of tuberous sclerosis complex (TSC) patients. Although these tumours are usually asymptomatic, lesions >3 cm in diameter are prone to bleeding and up to 10% of TSC patients may experience a massive and potentially fatal retroperitoneal haemorrhage. [...]
2017 - 10.1093/ckj/sfx094
Clinical Kidney Journal, Vol. 10 (september 2017) , p. 728-737  
3.
8 p, 727.2 KB Rare diseases, rare presentations : recognizing atypical inherited kidney disease phenotypes in the age of genomics / Ars Criach, Elisabet (Institut d'Investigació Biomèdica Sant Pau) ; Torra Balcells, Roser (Institut d'Investigació Biomèdica Sant Pau)
A significant percentage of adults (10%) and children (20%) on renal replacement therapy have an inherited kidney disease (IKD). The new genomic era, ushered in by the next generation sequencing techniques, has contributed to the identification of new genes and facilitated the genetic diagnosis of the highly heterogeneous IKDs. [...]
2017 - 10.1093/ckj/sfx051
Clinical Kidney Journal, Vol. 10 (july 2017) , p. 586-593  
4.
12 p, 666.2 KB Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease : a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice / Gansevoort, Ron T. (University Medical Center Groningen, University of Groningen) ; Arici, Mustafa (Hacettepe University Faculty of Medicine) ; Benzing, Thomas (University of Cologne) ; Birn, Henrik (Aarhus University) ; Capasso, Giovambattista (Second University of Naples) ; Covic, Adrian (and 'Grigore T. Popa' University of Medicine. C.I. PARHON' University Hospital) ; Devuyst, Olivier (UCL Medical School) ; Drechsler, Christiane (University Hospital. University of Würzburg) ; Eckardt, Kai-Uwe (Friedrich-Alexander University Erlangen-Nürnberg (FAU)) ; Emma, Francesco (Bambino Gesù Children's Hospital-IRCCS) ; Knebelmann, Bertrand (Paris Descartes University. Hôpital Necker) ; Le Meur, Yannick (Hôpital La Cavale Blanche, Centre Hospitalier Régional Universitaire de Brest) ; Massy, Ziad A. (University of Paris Saclay and Paris Ouest—Versailles-Saint-Quentin-en-Yvelines (UVSQ)) ; Ong, Albert C.M. (University of Sheffield Medical School) ; Ortiz, Alberto (IIS-Fundacion Jimenez Diaz-UAM and REDINREN) ; Schaefer, Franz (Heidelberg University Hospital) ; Torra, Roser (Institut d'Investigació Biomèdica Sant Pau) ; Vanholder, Raymond (Ghent University Hospital) ; Więcek, Andrzej (Medical University of Silesia in Katowice) ; Zoccali, Carmine (CNR-IFC Clinical Epidemiology and Pathophysiology of Renal Diseases and Hypertension Unit, Reggio Calabria c/o Ospedali Riuniti) ; Van Biesen, Wim (Ghent University Hospital) ; Universitat Autònoma de Barcelona ; Universitat Autònoma de Barcelona. Institut Puigvert
Recently, the European Medicines Agency approved the use of the vasopressin V2 receptor antagonist tolvaptan to slow the progression of cyst development and renal insufficiency of autosomal dominant polycystic kidney disease (ADPKD) in adult patients with chronic kidney disease stages 1-3 at initiation of treatment with evidence of rapidly progressing disease. [...]
2016 - 10.1093/ndt/gfv456
Nephrology Dialysis Transplantation, Vol. 31 (january 2016) , p. 337-348  
5.
7 p, 1.3 MB Insight into response to mTOR inhibition when PKD1 and TSC2 are mutated / Cabrera López, Cristina (Institut d'Investigació Biomèdica Sant Pau) ; Bullich Vilanova, Gemma (Institut d'Investigació Biomèdica Sant Pau) ; Martí, Teresa (Institut d'Investigació Biomèdica Sant Pau) ; Català, Violeta (Institut d'Investigació Biomèdica Sant Pau) ; Ballarín Castan, José Aurelio (Institut d'Investigació Biomèdica Sant Pau) ; Bissler, John J. (Pediatric Nephrology Department, Le Bonheur Children's Hospital, Memphis, TN USA) ; Harris, Peter C. (Department of Biochemistry and Molecular Biology, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN USA) ; Ars Criach, Elisabet (Institut d'Investigació Biomèdica Sant Pau) ; Torra Balcells, Roser (Institut d'Investigació Biomèdica Sant Pau)
Mutations in TSC1 or TSC2 cause the tuberous sclerosis complex (TSC), while mutations in PKD1 or PKD2 cause autosomal dominant polycystic kidney disease (ADPKD). PKD1 lays immediately adjacent to TSC2 and deletions involving both genes, the PKD1/TSC2 contiguous gene syndrome (CGS), are characterized by severe ADPKD, plus TSC. [...]
2015 - 10.1186/s12881-015-0185-y
BMC Medical Genetics, Vol. 16 (june 2015)  
6.
8 p, 444.5 KB Targeted next-generation sequencing in steroid-resistant nephrotic syndrome : mutations in multiple glomerular genes may influence disease severity / Bullich Vilanova, Gemma (Institut d'Investigació Biomèdica Sant Pau) ; Trujillano, Daniel (CIBER in Epidemiology and Public Health (CIBERESP)) ; Santín, Sheila (Institut d'Investigació Biomèdica Sant Pau) ; Ossowski, Stephan (Genomic and Epigenomic Variation in Disease Group, Centre for Genomic Regulation (CRG)) ; Mendizábal, Santiago (Pediatric Nephrology Department, Hospital Universitario La Fe) ; Fraga, Gloria (Pediatric Nephrology Department, Hospital de la Santa Creu i Sant Pau) ; Madrid, Álvaro (Pediatric Nephrology Department, Hospital Vall d'Hebron) ; Ariceta, Gema (Pediatric Nephrology Department, Hospital Vall d'Hebron) ; Ballarín Castan, José Aurelio (Institut d'Investigació Biomèdica Sant Pau) ; Torra Balcells, Roser (NInstitut d'Investigació Biomèdica Sant Pau) ; Estivill, Xavier (CIBER in Epidemiology and Public Health (CIBERESP)) ; Ars Criach, Elisabet (Institut d'Investigació Biomèdica Sant Pau) ; Instituto de Salud Carlos III
Genetic diagnosis of steroid-resistant nephrotic syndrome (SRNS) using Sanger sequencing is complicated by the high genetic heterogeneity and phenotypic variability of this disease. We aimed to improve the genetic diagnosis of SRNS by simultaneously sequencing 26 glomerular genes using massive parallel sequencing and to study whether mutations in multiple genes increase disease severity. [...]
2014 - 10.1038/ejhg.2014.252
European Journal of Human Genetics, Vol. 23 (november 2014) , p. 1192-1199  
7.
10 p, 715.2 KB Diagnosis of autosomal dominant polycystic kidney disease using efficient PKD1 and PKD2 targeted next-generation sequencing / Trujillano, Daniel (CIBER in Epidemiology and Public Health (CIBERESP)) ; Bullich Vilanova, Gemma (Institut d'Investigació Biomèdica Sant Pau) ; Ossowski, Stephan (Universitat Pompeu Fabra (UPF)) ; Ballarín Castan, José Aurelio (Institut d'Investigació Biomèdica Sant Pau) ; Torra Balcells, Roser (Institut d'Investigació Biomèdica Sant Pau) ; Estivill, Xavier (Dexeus Woman's Health, Hospital Universitary Quiron Dexeus) ; Ars Criach, Elisabet (Institut d'Investigació Biomèdica Sant Pau)
Molecular diagnostics of autosomal dominant polycystic kidney disease (ADPKD) relies on mutation screening of PKD1 and PKD2, which is complicated by extensive allelic heterogeneity and the presence of six highly homologous sequences of PKD1. [...]
2014 - 10.1002/mgg3.82
Molecular Genetics & Genomic Medicine, Vol. 2 (may 2014) , p. 412-421  
8.
7 p, 173.5 KB Hypertension in autosomal-dominant polycystic kidney disease (ADPKD) / Sans-Atxer, Laia (Hospital del Mar (Barcelona)) ; Torra, Roser (Universitat Autónoma de Barcelona. Departament de Medicina) ; Fernández-Llama, Patricia (Institut d'Investigació Biomèdica Sant Pau)
Cardiovascular (CV) complications are the major cause of death in autosomal-dominant polycystic kidney disease (ADPKD) patients. Hypertension is common in these patients even before the onset of renal insufficiency. [...]
2013 - 10.1093/ckj/sft031
Clinical Kidney Journal, Vol. 6 (april 2013) , p. 457-463  
9.
4 p, 153.0 KB Fabry disease : the many faces of a single disorder / Torra, Roser (Fundació Puigvert) ; Ortíz, Alberto (Universidad Autónoma de Madrid. IIS-Fundación Jiménez Díaz)
In 1898, two dermatologists, William Anderson in England and Johannes Fabry in Germany, separately described a disease characterized by skin lesions, known as angiokera-tomas. This issue contains two reports of Fabry disease (FD) patients presenting with proteinuric chronic kidney disease (CKD) but lacking angiokeratomas [1,2]. [...]
2012 - 10.1093/ckj/sfs124
Clinical Kidney Journal, Vol. 5 (october 2012) , p. 379-382  
10.
9 p, 537.7 KB Assessing the effectiveness of rapamycin on angiomyolipoma in tuberous sclerosis : a two years trial / Cabrera-López, Cristina (Institut d'Investigació Biomèdica Sant Pau) ; Martí, Teresa (Institut d'Investigació Biomèdica Sant Pau) ; Catalá, Violeta (Institut d'Investigació Biomèdica Sant Pau) ; Torres, Ferran (Institut d'Investigació Biomèdica Sant Pau) ; Mateu, Silvia (Institut d'Investigació Biomèdica Sant Pau) ; Ballarín, Jose (Institut d'Investigació Biomèdica Sant Pau) ; Torra, Roser (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Tuberous sclerosis (TS) is a rare autosomal dominant systemic disease with an estimated prevalence of 1/6000. Renal angiomyolipoma (AML) is a benign tumour with high morbidity frequently present in TS. [...]
2012 - 10.1186/1750-1172-7-87
Orphanet Journal of Rare Diseases, Vol. 7 (november 2012) , p. 87  

Articles : 11 registres trobats   1 - 10següent  anar al registre:
Documents de recerca 3 registres trobats  
1.
129 p, 1.6 MB Nefropatía tubulointersticial autosómica dominante / Ayasreh Fierro, Nadia, autor. ; Torra Balcells, Roser, supervisor acadèmic. ; Ars Criach, Elisabet, supervisor acadèmic. ; Benito Vales, S, (Salvador) supervisor acadèmic. ; Universitat Autònoma de Barcelona. Departament de Medicina.
La nefropatía tubulointersticial autosómica dominante (NTAD) es una enfermedad renal hereditaria que se caracteriza por un daño tubulointersticial crónico. Clínicamente cursa con una enfermedad renal crónica (ERC) de lenta evolución con ausencia o mínima proteinuria y ausencia de microhematuria, con una edad de enfermedad renal crónica terminal (ERCT) muy variable. [...]
[Bellaterra] : Universitat Autònoma de Barcelona, 2017.  
2.
87 p, 9.0 MB Molecular study of idiopathic nephrotic syndrome / Bullich Vilanova, Gemma ; Ars Criach, Elisabet, dir. ; Torra Balcells, Roser, dir. ; Nogués, C. (Carme) (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia
Aquesta tesi és una contribució al coneixement de les bases moleculars de la síndrome nefròtica idiopàtica concretament, la nefropatia membranosa idiopàtica i la síndrome nefròtica córtico-resistent (SNCR) o glomeruloesclerosis segmentària i focal (GESF). [...]
This thesis is a contribution to the knowledge of the molecular bases of idiopathic nephrotic syndrome specifically, the idiopathic membranous nephropathy and steroid-resistant nephrotic syndrome (SRNS)/ focal segmental glomerulosclerosis (FSGS). [...]

[Barcelona] : Universitat Autònoma de Barcelona, 2016
3 documents
3.
13 p, 158.1 KB Estudio clínico y mutacional de una cohorte de pacientes con mutación en el gen hnf1b / Ayasreh Fierro, Nadia ; Torra Balcells, Roser, dir. ; Universitat Autònoma de Barcelona. Departament de Medicina
HNF1B (Hepatocyte Nuclear Factor 1-B localizado en el cromosoma 17q21. 3) es un factor de transcripción con un papel fundamental en los primeros estadios del desarrollo y en la organogénesis de diferentes tejidos como el renal, hepático, pancreático o genital. [...]
2013  

Vegeu també: autors amb noms similars
4 Torra, R.
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.